Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Treasury Shares (2016 - 2025)

Amphastar Pharmaceuticals has reported Treasury Shares over the past 12 years, most recently at $408.1 million for Q4 2025.

  • Quarterly results put Treasury Shares at $408.1 million for Q4 2025, up 22.67% from a year ago — trailing twelve months through Dec 2025 was $408.1 million (up 22.67% YoY), and the annual figure for FY2025 was $408.1 million, up 22.67%.
  • Treasury Shares for Q4 2025 was $2.9 million at Amphastar Pharmaceuticals, up from $172920.0 in the prior quarter.
  • Over the last five years, Treasury Shares for AMPH hit a ceiling of $2.9 million in Q4 2025 and a floor of -$15.2 million in Q2 2025.
  • Median Treasury Shares over the past 5 years was $181380.0 (2022), compared with a mean of -$3.6 million.
  • Biggest five-year swings in Treasury Shares: grew 15.72% in 2021 and later soared 49.67% in 2025.
  • Amphastar Pharmaceuticals' Treasury Shares stood at $150.5 million in 2021, then rose by 25.95% to $189.5 million in 2022, then surged by 30.55% to $247.4 million in 2023, then surged by 34.47% to $332.7 million in 2024, then rose by 22.67% to $408.1 million in 2025.
  • The last three reported values for Treasury Shares were $408.1 million (Q4 2025), $387.7 million (Q3 2025), and $382.8 million (Q2 2025) per Business Quant data.